Skip to content

Clinical trials

Phase 3 Ovarian Neoplasms trials in Sweden

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Ovarian Neoplasms Phase: Phase 3 Country / region: Sweden Clear all

22 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20051
20094
20102
20111
20121
20131
20151
20161
20171
20182
20203
20251
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed17
Active, not recruiting3
Recruiting2

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Hoffmann-La Roche4
AstraZeneca2
European Organisation for Research and Treatment of Cancer - EORTC2
Tesaro, Inc.2
AGO Research GmbH1
AGO Study Group1
Amgen1
Arcagy Research1
Boehringer Ingelheim1
Daiichi Sankyo1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Ovarian Neoplasms22
Fallopian Tube Neoplasms6
Carcinoma, Ovarian Epithelial3
Peritoneal Neoplasms3
Neoplasms2
Anus Neoplasms1
Breast Neoplasms1
Colonic Neoplasms1
Endometrial Neoplasms1
Fibrosarcoma1

Trials

Showing 1 to 22 of 22. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.